{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T05:47:06Z","timestamp":1751348826361},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81360150"],"award-info":[{"award-number":["81360150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.exer.2018.01.017","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T13:00:05Z","timestamp":1517662805000},"page":"13-19","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A mouse model of a novel missense mutation (Gly83Arg) in a Chinese kindred manifesting vitreous amyloidosis only"],"prefix":"10.1016","volume":"169","author":[{"given":"Ling-xia","family":"Ran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-yong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-mei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-wang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2018.01.017_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1665-2681(19)32129-5","article-title":"Transthyretin familial amyloidotic polyneuropathy: histopathological study of the explanted livers","volume":"2","author":"Amante","year":"2003","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.exer.2018.01.017_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.febslet.2012.07.029","article-title":"Clearance of extracellular misfolded proteins in systemic amyloidosis: experience with transthyretin","volume":"586","author":"Almeida","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.exer.2018.01.017_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ana.410330116","article-title":"Low plasma apolipoprotein AII levels in human and mouse amyloidosis with mutant transthyretin (Met-30) gene","volume":"33","author":"Ando","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.exer.2018.01.017_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1432-2277.2012.01467.x","article-title":"No ocular involvement in familial amyloidotic polyneuropathy ATTR V30M domino liver recipients","volume":"25","author":"Beirao","year":"2012","journal-title":"Transpl. Int."},{"key":"10.1016\/j.exer.2018.01.017_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/mus.20503","article-title":"Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides","volume":"33","author":"Benson","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.exer.2018.01.017_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000213761","article-title":"Modeling familial amyloidotic polyneuropathy (transthyretin V30M) in Drosophila melanogaster","volume":"6","author":"Berg","year":"2009","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.exer.2018.01.017_bib7","first-page":"329","article-title":"Transthyretin Arg -83 mutation in vitreous amyloidosis","volume":"4","author":"Chen","year":"2011","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.exer.2018.01.017_bib8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S1097-2765(00)00117-9","article-title":"The beta-slip: a novel concept in transthyretin amyloidosis","volume":"6","author":"Eneqvist","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.exer.2018.01.017_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archophthalmol.2009.390","article-title":"Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients","volume":"128","author":"Hara","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2018.01.017_bib10","first-page":"248","article-title":"Transthyretin gene mutation and expression in patients with familial vitreous amyloidosis","volume":"31","author":"Jiang","year":"2015","journal-title":"Chin J Ocul Fundus Dis"},{"key":"10.1016\/j.exer.2018.01.017_bib11","first-page":"1497","article-title":"Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy","volume":"150","author":"Kohno","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2018.01.017_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/eye.2013.217","article-title":"Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation","volume":"28","author":"Liu","year":"2014","journal-title":"Eye"},{"key":"10.1016\/j.exer.2018.01.017_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/13816810.2011.599356","article-title":"Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg","volume":"33","author":"Long","year":"2011","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.exer.2018.01.017_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/eye.1991.19","article-title":"Ocular changes in familial amyloidotic polyneuropathy with dense vitreous opacities","volume":"5","author":"Monteiro","year":"1991","journal-title":"Eye"},{"key":"10.1016\/j.exer.2018.01.017_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11248-012-9632-0","article-title":"Human TTRV30M localization within podocytes in a transgenic mouse model of transthyretin related amyloidosis: does the environment play a role?","volume":"22","author":"Petrakis","year":"2013","journal-title":"Transgenic Res."},{"key":"10.1016\/j.exer.2018.01.017_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/13506129.2015.1126574","article-title":"A novel transthyretin Lys70Glu (p.Lys90Glu) mutation presenting with vitreous amyloidosis and carpal tunnel syndrome","volume":"23","author":"Raivio","year":"2016","journal-title":"Amyloid. Int. J. Exp. Clin. Invest. Offic. J. Int. Soci. Amyloidosis."},{"key":"10.1016\/j.exer.2018.01.017_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/YCO.0b013e3283523db6","article-title":"Recent progress in the understanding and treatment of nonepileptic seizures[J]","volume":"25","author":"Reuber","year":"2012","journal-title":"Curr. Opin. Psychiatr."},{"year":"2009","series-title":"Recent Advances in Transthyretin Evolution, Structure and Biological Functions","author":"Richardson","key":"10.1016\/j.exer.2018.01.017_bib18"},{"key":"10.1016\/j.exer.2018.01.017_bib19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1600-0420.2007.01098.x","article-title":"Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy","volume":"86","author":"Sandgren","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2018.01.017_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3129\/i09-023","article-title":"Oculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69His a","volume":"44","author":"Schweitzer","year":"2009","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.exer.2018.01.017_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000360790","article-title":"Vitreous amyloidosis as the presenting symptom of familial amyloid polyneuropathy TTR Val30Met in a Portuguese patient","volume":"5","author":"Seca","year":"2014","journal-title":"Case Rep. Ophthalmol."},{"key":"10.1016\/j.exer.2018.01.017_bib22","first-page":"230","article-title":"A new Arg54Gly transthyretin gene mutation associated with vitreous amyloidosis in Chinese","volume":"26","author":"Shi","year":"2011","journal-title":"Eye Sci."},{"key":"10.1016\/j.exer.2018.01.017_bib23","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.lfs.2013.10.031","article-title":"Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy","volume":"93","author":"Taguchi","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.exer.2018.01.017_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000213298","article-title":"Role of serum amyloid P component for systemic amyloidosis in transgenic mice carrying human mutant transthyretin gene","volume":"37","author":"Tashiro","year":"1991","journal-title":"Gerontology"},{"key":"10.1016\/j.exer.2018.01.017_bib25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/labinvest.3780246","article-title":"Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis","volume":"81","author":"Teng","year":"2001","journal-title":"Lab. Invest."},{"key":"10.1016\/j.exer.2018.01.017_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbrc.2006.11.045","article-title":"A transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR merabolisms","volume":"352","author":"Ueda","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2018.01.017_bib27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/labinvest.2011.195","article-title":"Aged vervet monkeys developing transthyretin amyloidosis with the human disease-causing Ile122 allele: a valid pathological model of the human disease","volume":"92","author":"Ueda","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.exer.2018.01.017_bib28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/aos.13425","article-title":"Familial vitreous amyloidosis resulting from transthyretin variant Gly83Arg","volume":"95","author":"Xie","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2018.01.017_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/13506120209114104","article-title":"Transthyretin amyloidosis associated with a novel variant (Trp41Leu) presenting with vitreous opacities","volume":"9","author":"Yazaki","year":"2002","journal-title":"Amyloid"},{"key":"10.1016\/j.exer.2018.01.017_bib30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/13506129.2014.892871","article-title":"Chinese familial transthyretin amyloidosis with vitreous involvement is associated with the transthyretin mutation Gly83Arg: a case report and literature review","volume":"21","author":"Yin","year":"2014","journal-title":"Amyloid"},{"key":"10.1016\/j.exer.2018.01.017_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.exer.2013.02.005","article-title":"Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor","volume":"110","author":"Zou","year":"2013","journal-title":"Exp. Eye Res."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448351730893X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448351730893X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T03:32:10Z","timestamp":1570678330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448351730893X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":31,"alternative-id":["S001448351730893X"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2018.01.017","relation":{},"ISSN":["0014-4835"],"issn-type":[{"type":"print","value":"0014-4835"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mouse model of a novel missense mutation (Gly83Arg) in a Chinese kindred manifesting vitreous amyloidosis only","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2018.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}